Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Bjpsych Open|June 27, 2025
A randomised controlled feasibility trial comparing culturally adapted psychoeducation and treatment as usual for persons with bipolar disorders in NigeriaDung Ezekiel Jidong, M Ishrat Husain, Tarela Juliet Ike, et al.
Archives of Suicide Research : Official Journal of the International Academy for Suicide Research|February 16, 2024
Perspectives on Self-Harm and Suicidal Ideation in Nigeria: A Mixed-Methods Study of Patients, Family Caregivers, Clinicians, and the PublicDung Ezekiel Jidong, Tarela Juliet Ike, Nusrat Husain, et al.
Nucleic Acids Research|August 16, 2024
Rational design of base, sugar and backbone modifications improves ADAR-mediated RNA editingGenliang Lu, Chikdu Shivalila, Prashant Monian, et al.
European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society|August 25, 2023
Incidence of surgical rib fixation at chest wall injury society collaborative centers and a guide for expected number of cases (CWIS-CC1)Evert Austin Eriksson, Mathieu Mathilde Eugene Wijffels, Adam Kaye, et al.
Nucleic Acids Research|January 14, 2026
RNA editing for the treatment of alpha-1 antitrypsin deficiencyPrashant Monian, Chikdu Shivalila, Genliang Lu, et al.
Biotechnology Progress|October 10, 2018
Transient CHO expression platform for robust antibody production and its enhanced N-glycan sialylation on therapeutic glycoproteinsXiaotian Zhong, Weijun Ma, Caryl L Meade, et al.
Nucleic Acids Research|February 2, 2022
Impact of guanidine-containing backbone linkages on stereopure antisense oligonucleotides in the CNSPachamuthu Kandasamy, Yuanjing Liu, Vincent Aduda, et al.
Molecular Therapy. Nucleic Acids|July 19, 2024
Preclinical evaluation of stereopure antisense oligonucleotides for allele-selective lowering of mutant HTTNaoki Iwamoto, Yuanjing Liu, Maria Frank-Kamenetsky, et al.
Mabs|September 3, 2013
CDR-restricted engineering of native human scFvs creates highly stable and soluble bifunctional antibodies for subcutaneous deliveryBrian J Fennell, Barry McDonnell, Amy Sze Pui Tam, et al.
Mabs|January 18, 2021
Discovery and optimization of a novel anti-GUCY2c x CD3 bispecific antibody for the treatment of solid tumorsAdam R Root, Gurkan Guntas, Madan Katragadda, et al.
Pageof 8